Imagion Biosystems has made the attached Appendix 3Y announcements in relation to change of Directors interest notice.
Read Appendix 3Y — Change in Director’s Interest Notice for
Home » Appendix 3Y — Change in Director’s Interest Notice
Imagion Biosystems has made the attached Appendix 3Y announcements in relation to change of Directors interest notice.
Read Appendix 3Y — Change in Director’s Interest Notice for
MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to report that it
1H2023 Highlights: Achieved enrolment target for Phase I study of MagSense® HER2 breast cancer detection; imaging results corroborated by independent panel of radiologists Announced plan
Dear Imagion Biosystems Shareholders, It has been an incredible first month ramping up as Chief Executive Officer with Team Imagion Biosystems. With this quarter’s 4C
We’re on a mission to make cancer more detectable.
Stay informed about our latest news and developments.
© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance